Glenmark Pharmaceuticals Share Price

ABOUT Glenmark Pharmaceuticals

• Industry Biotechnology & Drugs
• ISIN INE935A01035
• BSE Code 532296
• NSE Code GLENMARK

Glenmark Pharmaceuticals Limited is an India-based, research-led, global pharmaceutical company. The Company hosts a diverse portfolio spanning branded, generics, and over-the-counter (OTC) segments. The Company is focused on the therapy areas of Respiratory, Dermatology and Oncology. The Company also has a regional/country-specific presence in other therapeutic areas like diabetes, cardiovascular and oral contraceptives. The Company’s offerings include complex injectables and biologics, oral solids, liquids, topical products, respiratory mdi1/dpi2/nasal sprays. It is focused on developing products for markets such as India, Russia & CIS, Brazil, Asia and Africa. Its brands include RYALTRIS and SALMEX / ASTHMEX. RYALTRIS, the Company's first global branded specialty drug for treating symptoms of seasonal allergic rhinitis. The Company's subsidiaries include Glenmark Pharmaceuticals Inc., Ichnos Sciences Inc., and Glenmark Holding SA.

MANAGEMENT

• Glenn Saldanha Executive Chairman of the Board, Managing Director
• Anurag Mantri Global Chief Financial Officer, Executive Director
• Harish Kuber Compliance Officer, Company Secretary
• Cherylann Pinto Executive Director - Corporate Services